Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Springer full text link Springer Free PMC article
Full text links

Actions

Share

Comment
.2012 Dec;7(4):722-4.
doi: 10.1007/s11481-012-9398-4. Epub 2012 Aug 31.

The molecular basis for neuroimmune receptor signaling

Comment

The molecular basis for neuroimmune receptor signaling

Thomas J Rogers. J Neuroimmune Pharmacol.2012 Dec.

Abstract

Many of the receptors which are responsible for the responses to the common drugs of abuse belong to the G protein-coupled receptor (GPCR) family. In this special issue of the Journal of Neuroimmune Pharmacology a collection of papers is presented which deals with signaling events that are important for the function of these receptors. Because these receptors are expressed by both neuronal and immune cells, and because these receptors play a complex role in regulating function in both the nervous and immune systems, a more complete understanding of the regulation of expression of these receptors is essential. Moreover, once these receptors are expressed and activated, a complex series of signaling events are initiated that can have substantial significance. We have only a limited understanding of these signaling events, but with more complete information, we may be able to control the undesirable and/or desirable consequences of receptor activation by drugs of abuse.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: The author has no known conflicts of interest concerning the results reported in this manuscript.

Comment in

  • Change in evolution.
    Gendelman HE.Gendelman HE.J Neuroimmune Pharmacol. 2012 Dec;7(4):715-6. doi: 10.1007/s11481-012-9418-4. Epub 2012 Nov 13.J Neuroimmune Pharmacol. 2012.PMID:23150033No abstract available.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Hwang CK, Wagley Y, Law P-Y, Wei L-N, Loh HH. MicroRNAs In Opioid Pharmacology. J Neuroimmune Pharmacol. 2012 (in this issue) - PMC - PubMed
    1. Karmaus PWF, Chen W, Kaplan BLF, Kaminski NE. Δ9-Tetrahydrocannabinol Suppresses Cytotoxic T lymphocyte Function Independent of CB1 and CB2, Disrupting Early Activation Events. J Neuroimmune Pharmacol. 2012 (in this issue) - PMC - PubMed
    1. Mithal DS, Banisadr G, Miller RJ. CXCL2 Signaling In The Development Of The Nervous System. J Neuroimmune Pharmacol. 2012 (in this issue) - PMC - PubMed
    1. Panas MW, Xie Z, Panas HN, Hoener MC, Vallender EJ, Miller GM. Trace Amine Associated Receptor 1 Signaling in Activated Lymphocytes. J Neuroimmune Pharmacol. 2012 (in this issue) - PMC - PubMed
    1. Podhaizer EM, Zou S, Fitting S, Samano KL, El-Hage N, Knapp PE, Hauser KF. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J Neuroimmune Pharmacol. 2012 (in this issue) - PMC - PubMed

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Springer full text link Springer Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp